First Venture Technologies Corp. TSX VENTURE: FEB

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Feb. 5, 2007) - First Venture Technologies Corp. (TSX VENTURE:FEB) reports that Independent Equity Research Corp., operating as eResearch, has commenced analyst coverage of the company. Their initial report can be found at http://www.eresearch.ca/profile.asp?comp=429.

ON BEHALF OF THE BOARD

Geoff Lee, Director, Regional Development

ABOUT FIRST VENTURE TECHNOLOGIES

First Venture is a biotechnology company that develops and commercializes advanced yeast products.

The company is currently commercializing a platform yeast technology that substantially reduces the formation of a known carcinogen, ethyl carbamate (or urethane) from food products and alcoholic beverages. The company has licensed the exclusive worldwide rights to the technology from The University of British Columbia (UBC), and is developing the technology in partnership with UBC's world-renowned Wine Research Centre.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.